 |
Trial Information
Summary: Stimulant Drug Treatment of ADHD, Inattentive TypeThe purpose of this study is to examine and compare the
responses of children with different types of ADHD to standard
methylphenidate (Ritalin) treatment. Participation involves 5 weeks
of treatment: the dose of Ritalin will be gradually increased
during the first week of the study. The next 4 weeks consist of one
week on each of the 3 doses of methylphenidate and one week on
placebo (a pill without any active ingredients, i.e, without any
Ritalin) in random order. Random order means that for any of the
four weeks, the participant can get Ritalin (either low, medium or
high dose) or placebo. The participant does not know the order in
which the medication dosage is changed each week. After the
completion of the study, the participant is informed of the order
of dosages. Participation requires weekly visits to the clinic of
the parents and child. Completion of checklists by parents and
teacher is required on a weekly basis. Patient Inclusion/Exclusion Criteria: Children 7 to 12 years of age with ADHD, either Predominantly Inattentive or Combined Type. Children taking any other medication to treat ADHD.
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received. This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Trial listings updated: June 1, 2008 at 5:43:29 AM |
|
|
Patient Resources: [ Trial Listing
] [ Notification Services ] [ Drug
Directories ]
Copyright © 1995 - 2008, CenterWatch |
